Grossamide (GSE), a lignan amide derived from 6-thioguanosine, acts as a selective and potent microRNA-210 (miR-210) inhibitor. It functions by blocking pre-miR-210 processing and has been shown to induce apoptosis in breast cancer cells in vitro, supporting its research use in oncology and molecular biology.
